Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Clinical Trial Evaluating the Efficacy of a Unique Advanced Bioengineered Skin Substitute With Standard of Care Versus an Active Comparator With Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers
Conditions
Interventions
SOC and Advanced Bioengineered Skin Substitute
SOC and Active Comparator
Locations
3
United States
Clemente Clinical Research
Los Angeles, California, United States
Doctors Research Network
South Miami, Florida, United States
Foot and Ankle Specialists of the Mid-Atlantic
Salem, Virginia, United States
Start Date
July 25, 2024
Primary Completion Date
October 25, 2024
Completion Date
October 25, 2024
Last Updated
May 22, 2025
NCT07039396
NCT07396376
NCT07116876
NCT07198061
NCT07014176
NCT07109895
Lead Sponsor
Encoll Corp
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions